Terms: = Lung cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Prognosis
17 results:
1. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
[TBL] [Abstract] [Full Text] [Related]
2. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
3. Clinical effect of surgical treatment for lung metastasis and prognostic risk factor analysis: a single-centred cohort study.
Peng D; Sun W
ANZ J Surg; 2023 Jun; 93(6):1551-1558. PubMed ID: 37226585
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
[TBL] [Abstract] [Full Text] [Related]
5. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and prognostic implications of ALK rearrangement in patients with completely surgically resected lung adenocarcinoma.
Zhang H; Shan G; Cai B; Bi G; Chen Z; Liang J; Besskaya V; Zheng Y; Guo W; Wang L; Xu S; Zhan C
Thorac Cancer; 2021 Nov; 12(22):3011-3018. PubMed ID: 34596344
[TBL] [Abstract] [Full Text] [Related]
7. prognosis of patients with malignant mesothelioma by expression of programmed cell death 1 ligand 1 and mesothelin in a contemporary cohort in Finland.
Vizcaya D; Farahmand B; Walter AO; Kneip C; Jöhrens K; Tukiainen M; Schmitz AA
Cancer Treat Res Commun; 2020; 25():100260. PubMed ID: 33310366
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of metastatic pattern in colorectal cancer: a multicenter retrospective analysis in a real-life cohort.
Rumpold H; Kirchweger P; Niedersüß-Beke D; Falch D; Wundsam H; Metz-Gercek S; Piringer G; Thaler J
Acta Oncol; 2021 Feb; 60(2):180-186. PubMed ID: 33095652
[TBL] [Abstract] [Full Text] [Related]
9. Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell lung cancer.
Sequist LV; Gray JE; Harb WA; Lopez-Chavez A; Doebele RC; Modiano MR; Jackman DM; Baggstrom MQ; Atmaca A; Felip E; Provencio M; Cobo M; Adiwijaya B; Kuesters G; Kamoun WS; Andreas K; Pipas JM; Santillana S; Cho BC; Park K; Shepherd FA
Oncologist; 2019 Aug; 24(8):1095-1102. PubMed ID: 30975923
[TBL] [Abstract] [Full Text] [Related]
10. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract] [Full Text] [Related]
11. [Retrospective Study of Efficacy in BIM Gene Polymorphism on First-line EGFR-TKIs Treatment for Advanced lung Adenocarcinoma].
Qian K; Zhang Y; Zhi X
Zhongguo Fei Ai Za Zhi; 2017 Aug; 20(8):543-548. PubMed ID: 28855035
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
[TBL] [Abstract] [Full Text] [Related]
13. Does Tenascin have Clinical Implications in Pathological Grade of Glioma Patients?: A Systematic Meta-Analysis.
Kong X; Ma W; Li Y; Wang Y; Guan J; Gao J; Wei J; Yao Y; Lian W; Xu Z; Dou W; Xing B; Ren Z; Su C; Yang Y; Wang R
Medicine (Baltimore); 2015 Aug; 94(32):e1330. PubMed ID: 26266377
[TBL] [Abstract] [Full Text] [Related]
14. Safety and activity of the anti-cd79b antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study.
Palanca-Wessels MC; Czuczman M; Salles G; Assouline S; Sehn LH; Flinn I; Patel MR; Sangha R; Hagenbeek A; Advani R; Tilly H; Casasnovas O; Press OW; Yalamanchili S; Kahn R; Dere RC; Lu D; Jones S; Jones C; Chu YW; Morschhauser F
Lancet Oncol; 2015 Jun; 16(6):704-15. PubMed ID: 25925619
[TBL] [Abstract] [Full Text] [Related]
15. Association between occupational dust exposure and prognosis of idiopathic pulmonary fibrosis: a Korean national survey.
Lee SH; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Song JS; Shin JW; Yoo NS; Lee EJ; Lee JH; Jegal Y; Lee HK; Park MS
Chest; 2015 Feb; 147(2):465-474. PubMed ID: 25275573
[TBL] [Abstract] [Full Text] [Related]
16. MET gene copy number predicts worse overall survival in patients with non-small cell lung cancer (NSCLC); a systematic review and meta-analysis.
Dimou A; Non L; Chae YK; Tester WJ; Syrigos KN
PLoS One; 2014; 9(9):e107677. PubMed ID: 25232729
[TBL] [Abstract] [Full Text] [Related]
17. Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.
Hu J; Liu YL; Piao SL; Yang DD; Yang YM; Cai L
Lung Cancer; 2012 Sep; 77(3):593-9. PubMed ID: 22717106
[TBL] [Abstract] [Full Text] [Related]
